-
Taking semaglutide turns down food noise, research suggests
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna,... Read more -
About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna,... Read more -
Challenging negative data helps AI models better identify effective antibodies
Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a... Read more -
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug... Read more -
Treatment for rare genetic cause of sudden vision loss approved following clinical trial
A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of... Read more -
Epilepsy drug's feared fertility risks in men found to be minimal
A large-scale international study led by the University of Liverpool has found little evidence that sodium valproate significantly impairs male... Read more -
Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm
A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living... Read more -
New pill lowers stubborn BP in kidney patients
A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the progression of... Read more -
Half of people stop taking popular weight-loss drug within a year, study finds
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight.... Read more -
FDA approves Inlexzo for bladder cancer
The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types... Read more -
Cardiovascular disease risk prediction tool may help guide statin therapy
A cardiovascular disease (CVD) risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients... Read more -
Medications leave lasting mark on gut microbiome, even years after use
Medications taken years ago can continue to shape the human gut microbiome, according to a large-scale study from the University... Read more -
Decades-old drug deployed in fight against mitochondrial diseases
When doctors prescribe oxybutynin, it's usually for an unglamorous problem: bladder incontinence. But researchers have discovered a surprising new role... Read more -
Treating opioid addiction in jails: Study reports fewer overdoses and reduced reincarceration after release
A study published in The New England Journal of Medicine finds that individuals who received medication for opioid use disorder... Read more -
Chemotherapy plus natural extract castalin improves cancer drug effectiveness, study finds
Scientists have identified a natural extract that could help boost the effectiveness of cancer drugs. The insights gained from their... Read more
